Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth

Author's Avatar
May 05, 2025
Article's Main Image

Key Takeaways:

  • Twist Bioscience has launched Atlas Data Storage with significant backing, demonstrating strategic growth initiatives.
  • The company shows strong financial performance with a notable rise in Q2 revenue and improved gross margins.
  • Positive analyst forecasts suggest substantial upside potential from current stock levels.

Twist Bioscience (NASDAQ: TWST) has made significant strides by launching Atlas Data Storage, a new standalone venture focusing on DNA storage technology. This move is bolstered by a substantial $155 million investment, with Twist Bioscience retaining a 24% ownership stake. The company reported impressive financial results for the second quarter, with revenue climbing to $92.8 million—a robust 23% increase year-over-year. Additionally, gross margins saw an improvement, reaching 49.6%, attributed to heightened production volumes and operational efficiencies.

Analyst Predictions and Price Targets

1919423217274089472.png

The sentiment among Wall Street analysts remains optimistic for Twist Bioscience Corp (TWST, Financial). Based on projections by 11 analysts, the average one-year price target stands at $53.74. This target includes a high estimate of $65.00 and a low estimate of $45.00, indicating potential upside of 43.85% from the current trading price of $37.36. For more in-depth forecast data, visit the Twist Bioscience Corp (TWST) Forecast page.

Brokerage Recommendations and GF Value

The consensus recommendation from 13 brokerage firms rates Twist Bioscience Corp (TWST, Financial) at an average of 2.0, which aligns with an "Outperform" status. This rating suggests analysts are optimistic about the stock's potential, with the rating scale running from 1, representing a "Strong Buy," to 5, indicating a "Sell."

According to GuruFocus data, the estimated GF Value for Twist Bioscience Corp (TWST, Financial) in the next year is $59.61. This estimation implies a substantial upside of 59.56% from the current market price of $37.36. The GF Value is calculated based on the company's historical trading multiples, past growth trajectories, and future business performance predictions. For a comprehensive overview, check the Twist Bioscience Corp (TWST) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.